Catalyst Wire Dossier Catalyst Wire Dossier

cytarabine and daunorubicin hydrochloride

cytarabine and daunorubicin hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for cytarabine and daunorubicin hydrochloride, covering 2018-12-19 to 2018-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]

See pricing